BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25619110)

  • 21. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Static and dynamic predictors of criminal involvement among people with heroin dependence: findings from a 3-year longitudinal study.
    Marel C; Mills KL; Darke S; Ross J; Slade T; Burns L; Teesson M
    Drug Alcohol Depend; 2013 Dec; 133(2):600-6. PubMed ID: 24008022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome.
    Darke S; Ross J; Mills K; Teesson M; Williamson A; Havard A
    Drug Alcohol Rev; 2010 May; 29(3):250-5. PubMed ID: 20565516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trajectories of heroin use: 10-11-year findings from the Australian Treatment Outcome Study.
    Teesson M; Marel C; Darke S; Ross J; Slade T; Burns L; Lynskey M; Memedovic S; White J; Mills KL
    Addiction; 2017 Jun; 112(6):1056-1068. PubMed ID: 28060437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence.
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Feb; 81(3):293-300. PubMed ID: 16154714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Sep; 84(2):201-5. PubMed ID: 16580792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 33-year follow-up of narcotics addicts.
    Hser YI; Hoffman V; Grella CE; Anglin MD
    Arch Gen Psychiatry; 2001 May; 58(5):503-8. PubMed ID: 11343531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Sep; 24(5):425-32. PubMed ID: 16298837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims.
    Darke S; Duflou J; Kaye S
    Addiction; 2007 Nov; 102(11):1793-7. PubMed ID: 17784895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The onset of heroin use and criminal behaviour: does order make a difference?
    Kaye S; Darke S; Finlay-Jones R
    Drug Alcohol Depend; 1998 Dec; 53(1):79-86. PubMed ID: 10933342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M; Lynskey M
    Drug Alcohol Depend; 2004 Apr; 74(1):77-83. PubMed ID: 15072810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
    Stoové MA; Dietze PM; Jolley D
    Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
    Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009.
    Darke S; Mills KL; Ross J; Teesson M
    Drug Alcohol Depend; 2011 Jun; 115(3):190-5. PubMed ID: 21130585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.